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Background: Although reactive oxygen species (ROS) have 
been produced in both mouse bone marrow-derived 
dendritic cells (DCs) and XS-106 DCs by contact sensitizers 
and irritants in previous studies, the generation of ROS in 
human monocyte-derived DCs (MoDCs) and their role in 
contact hypersensitivity (CHS) has yet to be elucidated. 
Objective: The purpose of this study was to determine 
whether contact allergens and irritants induce ROS in 
MoDCs and, if so, to evaluate the role of contact allergen and 
irritant induced-ROS in MoDCs in CHS. Methods: 
Production of ROS was measured by 5-(and-6)-chloro-
methyl-2’,7’-dichlorodihydrofluorescein diacetate (CM- 
H2DCFDA) assay. Surface CD86 and HLA-DR molecules 
were detected by flow cytometry. Protein carbonylation was 
detected by Western blotting. Results: ROS were produced 
by contact allergens such as dinitrochlorobenzene (DNCB) 
and thimerosal and the irritant benzalkonium chloride 
(BKC). DNCB-induced, but not BKC-induced, ROS in-
creased surface CD86 and HLA-DR molecules on MoDCs 
and induced protein carbonylation. These changes were 
reduced in the presence of antioxidant N-acetyl cysteine. 
Conclusion: Our results suggest that DNCB-induced ROS 
may be different from those induced by irritant BKC. The 
DNCB-induced ROS may be associated with the CHS 
response, because they activate surface molecules on DCs 
that are important for generating immune reactions. (Ann 
Dermatol 22(3) 269∼278, 2010)
-Keywords-
Contact allergen, Contact dermatitis, Monocyte-derived 
dendritic cell, Reactive oxygen species
INTRODUCTION
Reactive oxygen species (ROS) are important players in 
host defenses against bacterial infection1,2, skin aging3,4, 
cancer5, and various chronic diseases6. However, little is 
known about the role of ROS in skin diseases7 and contact 
hypersensitivity (CHS). ROS are molecular oxygen deri-
vatives that have various functions in cells8. Besides acting 
as direct bacterial killing mechanisms, ROS also stimulate 
the immune response through activation of signaling 
pathways, upregulation of surface co-stimulatory mole-
cules, protein carbonylation, and secretion of pro- 
inflammatory cytokines such as IL-129. ROS induction and 
inactivation are tightly regulated by enzymatic and 
non-enzymatic antioxidant systems10. Interruption of this 
system can lead to increased amounts of ROS, especially 
secondary or toxic ROS that are potentially damaging to 
cellular macromolecules5,6.
Contact dermatitis is an inflammatory skin disorder caused 
by environmental skin-sensitizing substances and is 
classified into 2 types: allergic contact dermatitis (ACD) 
and irritant contact dermatitis (ICD). ACD is considered to 
be a cell-mediated, delayed-type hypersensitivity immune 
response11, whereas ICD is thought to be a non- 
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immunological, local inflammatory reaction to chemicals. 
As mentioned above, ROS can be important in CHS; for 
this reason, the ROS-inducing potential of various contact 
allergens and irritants in DCs has been studied.
Antigen presenting cells play an essential role in the T 
cell-mediated immune response12,13. In the skin, there are 
different antigen presenting cells localized in the epi-
dermis (Langerhans cells [LCs]) and dermis (dermal 
dendritic cells [DDCs]). However, after applying haptens 
to the epidermis of mice genetically engineered to be 
deficient in LCs, decreased CHS response was not 
observed14. Therefore, whether or not LCs are involved in 
the induction of CHS remains controversial. Recently 
DDCs were reported to be more important than LCs in 
CHS14. Monocyte-derived DCs (MoDCs) have similar 
characteristics to DDCs or interstitial DCs15. Therefore, 
MoDCs were used as the experimental model in the 
present study.
The purpose of this study was to determine whether ROS 
are induced by contact allergens and irritants in MoDCs 
and, if so, to evaluate the role of hapten or irritant 
induced-ROS in CHS.
MATERIALS AND METHODS
Reagents and stimulation of DCs
Contact allergens, such as 2,4-dinitrochlorobenzene 
(DNCB), 2,4-dinitrofluorobenzene (DNFB), 2,4,6-trinitro-
benzene sulfonic acid (TNBS) and thimerosal (Thim); 
irritants, such as benzalkonium chloride (BKC) and 
sodium dodecyl sulfate (SDS); N,N1-dicyclohexylcarbodii-
mide (DCCD), an ATP synthase inhibitor (ASI); and the 
antioxidant N-acetyl cysteine (NAC), were purchased from 
Sigma-Aldrich (Sigma, St. Louis, MO, USA). 5-(and-6)- 
chloromethyl-2’,7’-dichlorodihydrofluorescein diacetate 
(CM-H2DCFDA) was obtained from Molecular Probes 
(Eugene, OR, USA). X-VIVO 15 (BioWhittaker Cambrex, 
Walkersville, MD, USA), and recombinant human (rh) 
GM-CSF (Novartis Pharma GmbH, Nuremberg, Germany) 
and rhIL-4 (Strathmann Biotech GMBH, Hamburg, 
Germany) were purchased for MoDC generation. Imma-
ture MoDCs were treated with sublethal concentrations of 
chemicals with or without pretreatment with ROS 
inhibitors such as NAC and catalase. NAC was dissolved 
in warm phosphate buffered saline (PBS) immediately 
prior to pre-treatment. 30μM of DCCD, an ASI, was used 
as a positive control to induce ROS production from 
MoDCs. It was incubated with MoDCs for 30 min.
Generation of MoDCs
MoDCs were generated as previously described16,17. 
Briefly, mononuclear cells were separated by a density 
gradient using Ficoll-Paque PLUS (GE Healthcare Bio- 
Sciences AB, Uppsala, Sweden) and monocyte cells were 
isolated by the plastic adherence method, incubating the 
mononuclear cells in 3% X-VIVO for 40 min and washing 
vigorously with PBS to remove non-adherent lympho-
cytes. Isolated monocytes were cultured in 10% plasma in 
X-VIVO 15 for 6 days with 800 U/ml of rhGM-CSF and 
1,000 U/ml of rhIL-4. On alternate days, 1 ml of culture 
medium was removed and fresh medium containing 
rhGM-CSF and rhIL-4 was added.
ROS detection using CM-H2DCFDA by flow cyto-
metric analysis
After treatment with sublethal concentrations of chemi-
cals, MoDCs were harvested, washed twice with pre- 
warmed PBS, and resuspended in 50μl PBS. The cells 
were stained with 3μM CM-H2DCFDA at 37oC for 15 
min and washed twice with PBS. Before analysis, 10μl 
propodium iodide (PI) (100μg/ml) was added to exclude 
dead cells and to control toxicity of chemicals. Samples 
were analyzed by flow cytometry (FACSCalibur, Becton 
Dickinson, Mountain View, CA, USA) for fluorescence 
signals within the PI− populations.
The expression of surface molecules on MoDCs
To determine the phenotypes of DCs, the following 
surface molecules were analyzed by flow cytometry. 
Mouse monoclonal fluorescence-conjugated antibodies 
(mAbs) against CD86 (FITC), HLA-DR (FITC), CD80 (PE), 
and CD83 (PE) (BD Pharmingen, San Diego, CA, USA) 
and the appropriate isotype controls were used. After 
treatment with haptens or irritants for 24 and 48 h, 
MoDCs were harvested, washed, and stained with the 
above mAbs. Samples were analyzed by flow cytometry.
Cytokine production from MoDCs
Culture supernatants of MoDCs were analyzed by 
enzyme-linked immunosorbent assay (ELISA), according to 
the manufacturer’s provided protocols. IL-1β, TNFα, and 
IL-12p70 cytokines were purchased from R&D Systems 
Inc. (Minneapolis, MN, USA) and ELISA was performed 
according to the manufacturer’s protocol.
Protein extraction and Western blotting
The cytoplasmic and nuclear proteins were extracted 
using ProteoJET Cytoplasmic and Nuclear Protein Extrac-
tion Kit (Fermentas Inc, Baltimore, MD, USA) according to 
the manufacturer’s protocol. The protein concentrations 
were determined using BCA assay. 30μg of proteins were 
loaded by 10% SDS-PAGE and electrotransferred to poly-
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Table 1. The optimal concentrations of chemicals used
Chemical
Concentration
1 h 24 h 
BKC   20μM   2.5μM 
SDS  100μg/ml  12.5μg/ml 
TNBS  400μg/ml  50μg/ml 
DNCB   40μM   5μM 
DNFB  128μM  16μM
Thimerosal   40μg/ml   5μg/ml 
Hydroquinone  200μg/ml  25μg/ml 
CoCl2  600μM  75μM
NiSO4 1,200μM 150μM
The concentrations of various chemicals at which the percentage 
of live monocyte-derived dendritic cells (Annexin Y/PI) exceeded
90% when cultured for 1 and 24 h. BKC: benzalkonium chloride,
SDS: sodium dodecyl sulfate, TNBS: trinitrobenzene sulfonic 
acid, DNCB: dinitrochlorobenzene, DNFB: dinitrofluoroben-
zene.
vinylidene difluoride membranes (Millipore Corporation, 
Bedford, MA, USA). The membranes were incubated with 
anti-DNP (Cell Signaling, Beverley, MA, USA) antibodies 
at −4oC overnight. They were then washed, incubated 
further with HRP-conjugated, anti-rabbit IgG (1/1,000 
dilution), and detected using an ECL detection system 
(Amersham Biosciences, Piscataway, NJ, USA). An 
anti-actin antibody (Sigma) was used as a loading control 
at 1:5,000.
Statistical analysis
Production of ROS and expression of surface molecules 
were described through mean fluorescence intensity using 
flow cytometry. Data were analyzed using a Student’s 
t-test. For statistical analyses, we used SPSS version 13.0 
(SPSS Inc., Chicago, IL, USA). p-values ＜0.05 were 
considered to be significant.
RESULTS
Allergens (DNCB, TNBS, Thim, and DNFB) and 
irritants (BKC and SDS) produce ROS by MoDCs
After determining the optimal concentrations of chemicals 
to use (Table 1), immature MoDCs were exposed to 
contact allergens and irritants to examine ROS induction. 
Of the contact sensitizers studied, DNCB, TNBS, Thim, 
and DNFB were found to induce ROS. DNCB, TNBS, 
Thim and DNFB increased ROS production 3.8-fold, 
2.9-fold, 3.3-fold, and 1.5-fold, respectively, compared to 
the control. Of these, the relative increase of ROS 
production by DNCB, Thim, and DNFB were statistically 
significant (p-values were 0.031, 0.029, and 0.034, 
respectively). ROS production after treatment with HQ, 
cobalt, and nickel was not detectable (data not shown). Of 
the irritants used, BKC and SDS induced ROS significantly 
(the relative ROS increase with BKC was 2.6-fold and that 
with SDS was 2.0-fold; p-values were 0.028 and 0.013, 
respectively) (Fig. 1).
ROS induced by allergens cause protein carbonylation, 
but irritant-induced ROS do not
MoDCs were treated with DNCB and BKC and car-
bonylated proteins were detected using anti-DNP anti-
body by Western blotting. Although the allergen DNCB 
and the irritant BKC both induced ROS similarly, only 
DNCB exposure was associated with protein carbonyla-
tion (Fig. 2).
Contact sensitizer DNCB up-regulates the expression of 
CD86 and HLA-DR on MoDCs but irritant BKC does 
not
To demonstrate that immature MoDCs treated with DNCB 
and BKC have enhanced expression of CD80, CD86, 
CD83, and HLA-DR, we used flow cytometry analysis. 
CD86 and HLA-DR expression on MoDCs cultured with 
DNCB were increased 2.5-fold and 1.2-fold, respectively 
(with p-values of 0.018 and 0.033, respectively), com-
pared to that of the control, which was statistically 
significant (Fig. 3A, C and Table 2A), while CD80 and 
CD83 expression was not augmented by DNCB. In 
contrast, irritant BKC did not induce the expression of all 
surface molecules on MoDCs (Fig. 3B, D).
The effects of antioxidants on ROS production, express-
ion of surface molecules, and protein carbonylation
1) ROS production induced by DNCB and BKC was 
diminished in the presence of NAC
After demonstrating the production of ROS from MoDCs 
cultured with DNCB and BKC, the effect of the 
antioxidant NAC on these ROS production was examined 
(Fig. 4A). Pre-treatment of MoDCs with 5 mM of NAC 
reduced the ROS production induced by DNCB signi-
ficantly (the relative ROS increase with DNCB treatment 
was 3.8-fold while that with pre-treatment with NAC plus 
DNCB treatment was 0.56-fold p≤0.0001). BKC-induced 
ROS production was decreased by pre-treatment with 
NAC (the relative ROS increase of BKC was 2.6-fold while 
that with pre-treatment with NAC plus BKC treatment was 
0.70-fold).
2) Protein carbonylation induced by DNCB-derived 
ROS was decreased slightly by NAC
To confirm that protein carbonylation is induced by ROS, 
we used antioxidant NAC, expecting that protein car-
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Fig. 1. (A) Monocyte-derived dendritic cells (MoDCs) produce reactive oxygen species (ROS) after incubation with various chemicals 
including allergens and irritants. Immature MoDCs were incubated for 1 h with sublethal concentration of allergens, such as (a) 
dinitrochlorobenzene (DNCB), (b) thimerosal (Thim), (c) dinitrofluorobenzene (DNFB) and (d) trinitrobenzene sulfonic acid (TNBS); 
and irritants, such as (e) benzalkonium chloride (BKC) and (f) sodium dodecyl sulfate (SDS). ROS production was detected by 
CM-H2DCFDA assay. (A) Filled line represents control cells without CM-H2DCFDA staining; dotted line indicates physiologic ROS 
level in the cells (DCFDA staining only) without treatment; solid line indicates ATP synthase inhibitor (ASI)-treated cells as a positive 
control; solid thick line indicates ROS level induced by chemicals. Contact allergens DNCB, TNBS, Thim and DNFB increased ROS 
production 3.8-fold, 2.9-fold, 3.3-fold, and 1.5-fold, respectively, compared to the control. Irritants BKC and SDS induced ROS 
significantly (2.6-fold and 2.0-fold, respectively). (B) Relative increase of ROS after incubation with various chemicals including allergens 
and irritants. The relative increase in ROS was calculated by comparing the mean fluorescence intensity (MFI) of CM-H2DCFDA 
stained-treatment groups to that of the control group. Of these, the relative increases of ROS production by DNCB, Thim, and DNFB 
were statistically significant (p-values were 0.031, 0.029, and 0.034, respectively). Of the irritants used, BKC and SDS induced ROS 
significantly (p-values were 0.028 and 0.013, respectively).
bonylation would decrease as the amount of ROS 
decreased. After incubation of MoDCs treated with DNCB 
in the presence of 5 mM NAC, the carbonylated protein 
level was indeed found to be decreased (Fig. 4B).
3) Upregulation of CD86 and HLA-DR on MoDCs by 
DNCB-induced ROS was decreased by NAC
To verify that DNCB-induced up-regulation of CD86 and 
HLA-DR is related to the generation of ROS, we examined 
these parameters with the addition of the antioxidant 
NAC. MoDCs were treated with DNCB in the presence or 
absence of NAC and cell surface molecules were 
analyzed by flow cytometry. Augmentation of CD86 and 
HLA-DR by DNCB was decreased by adding 10 mM NAC 
(Fig. 4C and Table 2B).
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Table 2. The change of mean fluorescence intensity of surface
molecule expression on MoDC after incubation with contact 
allergen DNCB, irritant BKC, and cytokine cocktail as a positive
control
Table 2A
Groups
Surface molecules
CD80 CD83 CD86 HLA-DR
Untreated 35 10 230 400
DNCB 35 6.5 600 500
BKC 15 10 180 210
Cytokine cocktail 410 300 800 750
Mean fluorescence intensity.
Table 2B
Groups
Surface molecules
CD86 HLA-DR
Untreated 50 250
DNCB 120 800
NAC＋DNCB 85 550
Mean fluorescence intensity. MoDC: monocyte-derived dendritic
cells, DNCB: dinitrochlorobenzene, BKC: benzalkonium chlo-
ride, NAC: N-acetyl cysteine.
Fig. 2. Contact allergen-DNCB, but not irritant-BKC, induced 
protein carbonylation. Immature day 6 MoDCs were incubated
with 20μm DNCB and 10μM BKC for 6 h. Carbonylated groups
were detected by immunoblotting with an anti-DNP antibody.
DNCB treated cells but not BKC treated cells showed increased
carbonylation compared with the control. Actin is included as
a loading control. These data are representative of two 
independent experiments.
Fig. 3. Augmentation of CD86 and HLA-DR expression on MoDCs by DNCB but not by BKC. MoDCs were treated with 10μM 
DNCB or 5μM BKC for 24 h and then analyzed by flow cytometry. (A, B) Thick solid line indicates CD86 expression on MoDCs 
after treatment with DNCB and BKC, respectively; solid narrow line indicates positive control (treatment with cytokine cocktail); 
filled line indicates untreated DCs; dotted line indicates DCs stained with CD86 only. (C, D) Thick solid line indicates HLA-DR 
expression on MoDCs after treatment with DNCB and BKC, respectively; solid narrow line indicates positive control, filled line indicates 
untreated DCs, and dotted line indicates DCs stained with HLA-DR only. CD86 and HLA-DR expression on MoDCs cultured with 
DNCB was increased 2.5-fold and 1.2-fold respectively; p-values were 0.018 and 0.033, respectively, compared to that of the control.
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Fig. 4. (A) Hapten and irritant-induced ROS diminished by N-acetyl L-cystein. MoDCs were pre-treated with 5 mM NAC for 30 min 
and then treated with 30μM DNCB or 20μM BKC. After 1 h they were stained with 3 mM CM-H2DCFDA and analyzed by flow 
cytometry. The histogram of chemical-treated MoDCs in the presence or the absence of NAC is expressed as a thick solid line or 
solid line, whereas a filled line or a dotted line indicates histograms of untreated DCs or of DCs stained with CM-H2DCFDA, respectively. 
Pre-treatment of MoDCs with 5 mM of NAC reduced the ROS production induced by DNCB significantly (the relative ROS increase 
with DNCB treatment was 3.8-fold while that with pre-treatment with NAC plus DNCB treatment was 0.56-fold. p≤0.0001). 
BKC-induced ROS production was decreased by pre-treatment with NAC (the relative ROS increase with BKC treatment was 2.6-fold 
while that with pre-treatment with NAC plus BKC treatment was 0.70-fold). Each experiment was repeated three times and one 
representative result is shown. (B) These carbonylated proteins were decreased slightly by NAC. Immature day 6 MoDCs were incubated 
with 20μM DNCB or 10μM BKC in the presence or absence of 5 mM NAC for 30 min. After 6 h, equal amounts of whole cell 
protein extracts were loaded in SDS gel and carbonylated proteins were detected using DNP antibody by Western blotting. Allergen 
DNCB but not irritant BKC induced protein carbonylation and the resulting carbonylated protein was decreased slightly by NAC. 
(C) NAC suppressed the augmentation of CD86 and HLA-DR molecules on MoDCs that were induced by contact allergen DNCB. 
MoDCs were cultured with DNCB in the presence or absence of pre-treatment 5 mM NAC. After 24 h their surface molecules were 
analyzed by flow cytometry. Thick solid line indicates the histogram of chemical-treated MoDCs with NAC; narrow solid line indicates 
treatment without NAC; filled line indicates non-treatment; dotted line indicates treatment with CD86 antibody only. Augmentation 
of CD86 and HLA-DR by DNCB was decreased by adding 10 mM NAC.
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Fig. 5. Inhibition of ROS generating pathway. (A) DNCB induced-ROS blocked by NADPH synthase inhibitor DPI. MoDCs were
treated with 20μM DNCB for 1 h in the presence (thick solid line) or absence (solid narrow line) of DPI (a specific blocker of 
NADPH oxidase). Filled line indicates no staining, while dotted line indicates staining with CM-H2DCFDA only. (B) BKC induced-ROS
blocked slightly by iNOS inhibitor NMMA. MoDC treated with 10μM BKC in the absence (solid narrow line) or presence (thick
solid line) of NMMA.
Table 3. Effect of various ROS inhibitors on induction of ROS
by BKC and DNCB
ROS 
generator
ROS inhibitor
Antioxidant Enzymatic inhibitor
ROS generating 
pathway blockers
NAC Catalase DPI NMMA
BKC ＋ ＋ − ＋
DNCB ＋ ＋ ＋ −
ROS: reactive oxygen species, BKC: benzalkonium chloride, 
DNCB: dinitrochlorobenzene, NAC: N-acetyl cysteine, DPI: 
diphenylene iodonium, NMMA: N-monomethyl-L-arginine, ＋: 
reduction of ROS, −: no effect on ROS level.
Table 4. The production of cytokines from MoDCs after 
incubation with contact allergen-DNCB and irritant-BKC
Groups
At protein level (mean±SD, pg/ml)
IL-1β IL-12p70 TNF-α
Control group ND ND 34.5±55.8
DNCB ND ND 63.1±50.9
BKC ND ND 92.8±22.7
MoDC: monocyte-derived dendritic cells, DNCB: dinitrochloro-
benzene, BKC: benzalkonium chloride, SD: standard deviation,
ND: not detectable.
Allergen and irritant-induced ROS generated from 
different sources
Allergen- and irritant-induced ROS may have a distinct 
role depending on their source. The source of ROS 
generated by each substance was examined and we found 
that contact allergen DNCB induced-ROS are reduced in 
the presence of diphenylene iodonium (DPI) (Fig. 5A) 
while the irritant BKC induced-ROS are decreased slightly 
by N-monomethyl-L-arginine (NMMA) (Fig. 5B and Table 3).
Cytokine production of MoDCs treated with DNCB 
and BKC
Cytokine secretion (IL-1β, IL-12p70, and TNFα) was 
assayed with ELISA in MoDCs treated by the contact 
allergen DNCB or the irritant BKC. TNF-α secretion in the 
DNCB- and BKC-treated MoDCs were increased by 
1.8-fold and 2.7-fold respectively compared to the control, 
but these increments were not statistically significant. 
Other cytokines (IL-1β, IL-12p70) were not detectable in 
the DNCB- and BKC-treated MoDCs (Table 4).
DISCUSSION
Using the well-established mouse XS-106 DC line and 
mouse bone marrow-derived DCs, we previously demon-
strated that contact allergens induce ROS, which in turn 
stimulate IL-12 cytokine secretion and the Th1 response 
during CHS9,18. We therefore sought to confirm the result 
in the human system. In the first part of this experiment, 
the optimal concentration of haptens and irritants, at 
which the percentage of live cells exceeded 90%, was 
found after incubation with these substances for 1 h and 
24 h (Table 1). Subsequently, ROS levels were measured 
to determine whether these chemicals did in fact induce 
ROS in MoDCs, which was confirmed. The ASI, N,N1- 
DCCD, was used as a positive control and catalase was 
used as an enzymatic inhibitor of ROS. The results were 
similar to those of our previous study18. However, some of 
the contact sensitizers, such as nickel, did not generate 
ROS in amounts detectable by CM-H2DCFDA assay. 
Other studies have reported that both DNCB and nickel 
induce redox imbalances and further increase surface 
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molecules on DCs19,20. The conflicting data can be 
explained by the usage of different ROS detection assays. 
Although there are several assays used to measure levels 
of ROS21-24, we chose CM-H2DCFDA as it is a 
widely-used, simple assay. CM-H2DCFDA is sensitive to 
oxidation by peroxynitrite (ONOO−) and hydrogen 
peroxide (H2O2) in the presence of cellular peroxidase 
and hydroxyl radicals (OH−). Unfortunately, it may have 
some disadvantages. For example, it is not suitable for 
measurement of nitric oxide (NO), hypochlorite (HOCl), 
or superoxide (O2−) in biological systems21. ROS 
detection by the CM-H2DCFDA method does not have 
selectivity; it reacts with many ROS and does not 
distinguish between the different types22. ROS is a general 
term given to a variety of ROS and radicals. It is possible 
that each different allergen and irritant may induce a 
distinct type of ROS with different types having different 
roles in contact dermatitis.
After confirming the generation of ROS, we sought to 
determine the distinct effects of contact sensitizer induced- 
and irritant induced-ROS on DC activation. ROS seem to 
have two primary roles. First, ROS can act as second 
messengers that alter DC function during antigen 
presentation when induced in moderate concentrations. 
The signal may depend on the type of ROS; for example, 
weak oxidizing (moderately toxic) ROS such as hydrogen 
peroxide and superoxide may be important for organ 
development25, secondary signal transduction6,8 and 
immune system enhancement9 while highly toxic ROS 
such as peroxynitrite, hydroxyl radicals, and hypochlorate 
may be transducers of cell death signaling pathways26. 
Secondly, ROS may induce oxidative stress, which arises 
when the concentration of ROS exceeds the cell’s ability 
to neutralize them and repair cellular damage. Ultimately, 
this results in the widespread oxidation of biomolecules. 
ROS are mainly generated by mitochondrial electron 
transport systems I and III (ETS-I and III), nicotinamide 
adenine dinucleotide phosphate (NADPH) oxidase, xan-
thine oxidase, nitric oxide synthase (NOS), cyclooxy-
genase (COX), and ribonucleotide reductase systems27. 
From the above results, it can be postulated that 
BKC-induced ROS may consist of nitric oxides or highly 
toxic peroxynitrite, while contact allergen induced-ROS 
may consist of hydrogen peroxide or superoxide, which 
are derived from the NOX2 pathway.
ROS can cause a number of protein modifications, such as 
protein carbonylation and modification of protein side 
chains2. Carbonylation results from direct oxidation of 
amino acids side chains. Since carbonylation involves the 
addition of a relatively large and reactive group to the 
peptide backbone, it can have a variety of effects on the 
protein’s properties, including covalent intermolecular 
cross-linking and cleavage to yield lower molecular 
weight species2,28. Our study revealed that contact aller-
gen DNCB was associated with protein carbonylation 
detectable by DNP immunoblotting while BKC was not. 
This suggests that protein carbonylation might be involved 
in the pathogenesis of CHS. This result is similar to the 
results of our previous study9. Incubation with the 
thiol-containing antioxidant NAC reduced the amount of 
carbonylated protein. Although the decrease in the car-
bonylated protein level was small, this finding suggests 
that protein carbonylation may be caused by ROS.
Antioxidants and ROS scavengers appear to have anti- 
inflammatory effects, likely by counteracting the effects of 
ROS. Therefore, we examined the levels of hapten- 
induced ROS in the presence of antioxidants. Although 
several antioxidants, such as Vitamins E and A, alpha- 
lipoic acid, and glutathione (GSH), did not reduce the 
ROS level (data not shown), incubation with NAC 
decreased both DNCB- and BKC-induced ROS. GSH is a 
key component in protection against oxidative stress 
because it is a co-factor of several antioxidant enzymes 
and scavenges OH− and O− directly. It also is able to 
regenerate other important antioxidants such as vitamins C 
and E back to their active forms29. Pretreatment with GSH 
alone did not affect the ROS level; however, its precursor 
NAC did reduce the ROS level. This may be due to the 
fact that high concentrations of reduced GSH in the cell 
interfere with the diffusion of GSH into cells. GSH is 
abundant in the cytoplasm (1∼11 mM), in the 
mitochondria (3∼11 mM), and in the nucleus (5∼15 
mM)30.
Surface molecule expression varied depending on the 
chemicals that were applied to cells. Expression of CD86, 
ICAM (CD54) and HLA-DR molecules on MoDCs was 
upregulated by contact allergens31 while the amount of 
CD80 and CD83 molecules was not increased. Our study 
demonstrated that these upregulations were dependent on 
the ROS. Rutault et al.20 reported that hydrogen peroxide 
induces upregulation of several DC surface molecules, 
such as MHC class II and co-stimulatory molecules 
including CD40 and CD86, and that this enhancement is 
blocked by NAC. These results confirm the results of our 
previous studies9,18 which showed that ROS produced by 
contact allergen increase surface molecules and produce 
cytokines such as IL-12p70 in mouse XS-106 DCs cell 
lines9 and mouse bone-marrow derived DCs18. This study 
also proves that the results obtained from the mouse 
system are similar to that of the human system. Irritant 
BKC did not cause an increase in any of the co-stimulatory 
molecules on MoDCs. Even though both DNCB and BKC 
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produced ROS from MoDCs, the ROS produced by DNCB 
and BKC have different roles in the change of surface 
molecules of MoDCs. Therefore, it may be useful to 
further characterize the types of ROS produced by DNCB 
and BKC in future studies. Furthermore, it may be 
necessary to use other detection methods besides the 
CM-H2DCFDA assay.
Among the cytokines (IL-1β, IL-12p70, and TNFα) 
involved in CHS, only TNF-α secretion was detected after 
treatment with DNCB and BKC in this study. Other groups 
have also reported the detection of TNF-α at mRNA 
level32 and small amounts of TNF-α at the protein level 
after treatment with DNCB33. Cytokines (IL-1β, IL-12p70) 
at the protein level in MoDCs were undetected both in the 
control and experimental groups in this study. Contact 
allergen and irritant alone may not be sufficient stimulus 
leading to the secretion of the biologically active form of 
IL-1β, but when combined with other molecules such as 
LPS or TNF-α, they can further enhance the production of 
IL-1β34. IL-12p70 was easily secreted by mouse XS-106 
DCs after incubation with contact allergen9 in our 
previous study. We could not detect, however, any trace 
of IL-12p70 in the control and experimental groups in this 
experiment. This may be explained through the fact that 
MoDCs, different from the mouse XS106 DCs line, do not 
typically secrete IL-12p70.
The mere fact that ROS, in the process of antigen 
presentation, play a role in the activation of DCs and their 
interactions with T cells35, together with the fact that 
extracellular superoxide dismutase impairs LC migration 
and therefore suppresses mouse CHS36, confirms the 
involvement of ROS in CHS. Our study has further 
demonstrated the involvement of ROS in CHS through 
hapten-induced ROS production in human MoDCs, 
similar to that of the involvement of ROS in mouse CHS, 
which was shown through hapten-induced ROS pro-
duction in mouse XS 106 DC line9 and mouse bone 
marrow DCs18.
In conclusion, our results suggest that DNCB and BKC 
may induce different ROS in MoDCs. DNCB-induced 
ROS may induce the CHS response by activating DC.
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